Please assess the completion status of the following clinical trial:

Trial Title: Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetes~* Insufficiently controlled after 3 months of treatment with OADs (oral anti-diabetic drugs)~Exclusion Criteria:~* Previously treated with liraglutide~* Hypersensitivity to liraglutide or to any of the excipients (Disodium phosphate dihydrate, propylene glycol, phenol, water for injections)~* Pregnant, breast feeding or have the intention of becoming pregnant

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).